*Some Market data delayed by 15 mins.

Actinium Pharmaceuticals, Inc

Symbol: ATNM (NYSE)
1.68 ▲ (4.04%) 0.065

Company Description:
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Key Stats
  • Today's Open: $1.63
  • Today's High: $1.675
  • Today's Low: $1.576
  • Today's Volume: 57.45K
  • Yesterday Close: $1.61
  • Yesterday High: $1.67
  • Yesterday Low: $1.56
  • Yesterday Volume: 144.15K
  • Last Min Volume: 25
  • Last Min High: $1.675
  • Last Min Low: $1.671
  • Last Min VWAP: $1.6742
Company Profile
  • Name: Actinium Pharmaceuticals, Inc
  • Website: https://www.actiniumpharma.com
  • Listed Date: 2007-07-19
  • Location: NEW YORK, NY
  • Market Status: Active
  • CIK Number: 0001388320
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $50.23M
  • Round Lot: 100
  • Outstanding Shares: 31.20M
  • Asset Type: CS
RECENT FILINGS FOR ATNM
Filing Date Filing Type Format
2025-08-20 4 View
2025-08-08 10-Q View
2025-07-29 SCHEDULE 13G/A View
2025-07-16 SCHEDULE 13G/A View
2025-05-09 10-Q View
2025-05-09 8-K View
2025-04-02 4 View
2025-04-02 4 View
2025-04-02 4 View
2025-04-02 4 View
2025-04-02 4 View
2025-04-02 4 View
2025-04-02 4 View
2025-03-31 10-K View
2024-11-27 8-K View
2024-11-14 10-Q View
2024-11-12 SC 13G/A View
2024-11-08 SC 13G/A View
2024-11-06 ARS View
2024-11-05 4 View
Latest News on ATNM

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.